× Didn't find what you were looking for? Ask a question
Top Posters
Since Sunday
r
5
m
5
h
5
r
5
t
5
B
5
P
5
s
5
m
5
c
5
c
4
4
New Topic  
Fat Fat
wrote...
Posts: 752
Rep: 0 0
6 years ago
A researcher is studying the likely occurrence rate of secondary cancers after a new schedule of chemotherapy for childhood leukemia, using a biochemical marker obtained by blood draw six months after the initiation of chemotherapy.
 
  What is the rationale for using this marker as a proximate outcome, rather than counting the actual rate of secondary cancers?
  a. Research on recurrent cancers in children labels them as vulnerable, causing psychological harm.
  b. The final endpoint is not obtainable over a reasonable span of time, since secondary cancers can occur at any age.
  c. Most proximate endpoints are unreliable variables and should not be used unless there are no final endpoints.
  d. The researcher is not interested in whether children suffer a secondary malignancy; the researcher is merely interested in the marker value.
Read 68 times
1 Reply
Replies
Answer verified by a subject expert
Beehappy2Beehappy2
wrote...
Top Poster
Posts: 874
Rep: 5 0
6 years ago
Sign in or Sign up in seconds to unlock everything for free
This verified answer contains over 100 words.
1

Related Topics

Fat Author
wrote...

6 years ago
Smart ... Thanks!
wrote...

Yesterday
I appreciate what you did here, answered it right Smiling Face with Open Mouth
wrote...

2 hours ago
Thank you, thank you, thank you!
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers
  949 People Browsing
Related Images
  
 237
  
 323
  
 165